Evidence map›Paper›PMID 9120022›Full record

ArticleThe Journal of clinical investigation1997

Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids.

C M Lilly, H Nakamura, H Kesselman, C Nagler-Anderson, K Asano, E A Garcia-Zepeda, M E Rothenberg, J M Drazen, A D Luster

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
15.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 367 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Eosinophils: old cells, new directions.Frontiers in medicine · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. An update on the diagnostic biomarkers for asthma.Journal of family medicine and primary care · 2021
    Review
  16. Article
  17. Review
  18. EAACI Allergen Immunotherapy User's Guide.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2020
    Review
  19. Article
  20. Paucigranulocytic asthma: Uncoupling of airway obstruction from inflammation.The Journal of allergy and clinical immunology · 2019
    Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

C M LillyDepartment of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
H Nakamura
H Kesselman
C Nagler-Anderson
K Asano
E A Garcia-Zepeda
M E Rothenberg
J M Drazen
A D Luster
Brigham and Women's Hospital · USHarvard University · US

Funding

Lung-Resident Memory Th2 cells in Asthma - New Therapeutic TargetsR01AI040618 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LUSTER, ANDREW D · 1997 to 2022
$5.6M
NHLBI NIH HHS HL-03283NIAID NIH HHS AI 40618NIDDK NIH HHS DK-43551
6 · The paper itself

Abstract

Eotaxin is a potent and specific eosinophil chemoattractant that is mobilized in the respiratory epithelium after allergic stimulation. Pulmonary levels of eotaxin mRNA are known to increase after allergen exposure in sensitized animals. In this study we demonstrate that TNF alpha and IL-1beta induce the accumulation of eotaxin mRNA in the pulmonary epithelial cell lines A549 and BEAS 2B in a dose-dependent manner. Cytokine-induced A549 cell mRNA accumulation was maximal at 4 h and was significantly enhanced when the cells were costimulated with IFNgamma. TNFalpha- and IL-1beta-induced increases in eotaxin mRNA were diminished in a dose-dependent manner by the glucocorticoid dexamethasone and were augmented by the protein synthesis inhibitor cycloheximide. Cytokine-induced increases in eotaxin mRNA expression correlated with increased eotaxin protein production and secretion, and dexamethasone inhibition of cytokine-induced eotaxin mRNA augmentation was associated with diminished eotaxin protein secretion. These findings, together with the known kinetics of TNF alpha and IL-1beta mobilization in asthmatic airways and the potent eosinophil chemotactic effects of eotaxin, define a mechanism linking inflammatory cytokine mobilization to eosinophil recruitment that may be relevant to the pathogenesis of asthma.

Indexed as

Chemokines, CCAnimalsChemokine CCL11Chemotactic Factors, EosinophilCytokinesDexamethasoneDose-Response Relationship, DrugEpitheliumHumansInterferon-gammaInterleukin-1LungMiceMice, Inbred BALB CProtein Synthesis InhibitorsRabbitsCCL11 protein, humanCcl11 protein, mouseChemokine CCL11Chemokines, CCChemotactic Factors, EosinophilCytokinesDexamethasoneInterferon-gammaInterleukin-1Protein Synthesis InhibitorsRNA, Messenger

Identifiers

PMID9120022
PMCPMC507998
OpenAlexW1967777975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.